CLASS II ONGOING Device recall · Reported 26 Apr 2023 · FDA Enforcement Report

TD I-110 Speech Device-tablet style speech generating recalled

Tobii Dynavox is recalling Tobii Dynavox TD I-110 Speech Device-tablet style speech generating device used for, distributed nationwide in the US. The recall was initiated on 24 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 7340074601714 Serial Numbers: TD110-211005000001 through TD110-220927004400
Quantity recalled3924 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1399-2023
FDA event ID
91884
Recalling firm
Tobii Dynavox, Pittsburgh, PA
Classification
Class II
Status
Ongoing
Recall initiated
24 Feb 2023
FDA classified
18 Apr 2023
Reported
26 Apr 2023
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Device Malfunction

Timeline

24 Feb 2023Recall initiated by company
18 Apr 2023Classified by FDA+53 days
26 Apr 2023Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Problem maintaining the stable placement of the battery may come loose from the housing and become damaged.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Tobii Dynavox TD I-110 Speech Device-tablet style speech generating device used for ambulatory people with disabilities. Catalog #: 750567

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Belgium, Brazil, Canada, Croatia, Denmark, Estonia, Finland, France, Germany, Iceland Ireland, Italy, Latvia, Netherlands, Norway, Saudi Arabia, Slovakia, Slovenia, Sweden, United Arab Emirates, United Kingdom.

Nationwide

Questions about this recall

Is TD I-110 Speech Device-tablet style speech generating device used for ambulatory people recalled?

Yes. Tobii Dynavox recalled TD I-110 Speech Device-tablet style speech generating device used for ambulatory people on 24 Feb 2023. The recall is Class II and its status is Ongoing. Recall number Z-1399-2023.

Why was it recalled?

Problem maintaining the stable placement of the battery may come loose from the housing and become damaged.

Which lots are affected?

UDI: 7340074601714 Serial Numbers: TD110-211005000001 through TD110-220927004400

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Belgium, Brazil, Canada, Croatia, Denmark, Estonia, Finland, France, Germany, Iceland Ireland, Italy, Latvia, Netherlands, Norway, Saudi Arabia, Slovakia, Slovenia, Sweden, United Arab Emirates, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Tobii Dynavox

All 3

Other Other Medical Devices recalls

All 13,778